Freire named Biogen chair; Immunic seeking new CEO

Beyond Sanofi replacing Paul Hudson as CEO, the other large biopharma to make a high-profile change in its ranks was Biogen, which named Maria Freire as its new chair.

Freire, a board member of  Biogen Inc. (NASDAQ:BIIB) since 2021, is succeeding Caroline Dorsa, who is retiring. Freire serves on multiple boards and previously served as president and executive director of the Foundation for the National Institutes of Health (FNIH). The move will be effective after Biogen’s annual stockholder meeting on June 9...